title: Mechanisms of negative inotropic effects of class Ic antiarrhythmic agents: comparative study of the effects of flecainide and pilsicainide on intracellular calcium handling in dog ventricular myocardium.
abstract: We studied the subcellular mechanisms responsible for the negative inotropic effects of the two Ic drugs flecainide and pilsicainide. Aequorin luminescence (Ca2+i) and isometric tension were recorded simultaneously in isolated trabeculae from the dog ventricle. In isolated myocytes from the same ventricle, the slow inward current (ICa) was recorded. Both flecainide and pilsicainide decreased peak Ca2+i, peak tension, and peak ICa concentration dependently. Each effect with flecainide was more marked than that with pilsicainide; however, Ca2+i and ICa paralleled each other in changes in tension, and the tension-Ca2+i-ICa relationship showed the same curve for each drug. We conclude that the difference in negative inotropic effects of these class Ic drugs are primarily related to their effects on L-type Ca2+ channels and the subsequent decreases in the amount of Ca2+ released from the sarcoplasmic reticulum (SR) during each cardiac cycle. Therefore, their negative inotropic effects may not be directly correlated with the essential mechanisms responsible for their antiarrhythmic action.
authors.affiliation: Second Department of Internal Medicine, Toyama Medical and Pharmaceutical University School of Medicine, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Kihara
authors.forename: M
authors.initials: M
authors.lastname: Inoko
authors.forename: N
authors.initials: N
authors.lastname: Hatakeyama
authors.forename: Y
authors.initials: Y
authors.lastname: Momose
authors.forename: S
authors.initials: S
authors.lastname: Sasayama
mesh_terms: D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism* / Q000502:physiology; D015220:Calcium Channels / Q000187:drug effects*; D003864:Depression, Chemical; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005424:Flecainide / Q000494:pharmacology*; D006352:Heart Ventricles / Q000187:drug effects; D008012:Lidocaine / Q000031:analogs & derivatives* / Q000494:pharmacology; D009200:Myocardial Contraction / Q000187:drug effects*; D009206:Myocardium / Q000378:metabolism; D012508:Sarcolemma / Q000187:drug effects / Q000378:metabolism
chemical_list: D000889:Anti-Arrhythmia Agents; D015220:Calcium Channels; D008012:Lidocaine; C042288:pilsicainide; D005424:Flecainide; D002118:Calcium